In sum, the mouse modeling experiments demonstrated a nearly 100% incidence of PDGF-induced gliomas arising from GFAP-expressing cells in all three locations in the brain, with an equal latency between SVZ and cortex and a longer latency in the cerebellum. This evidence concerns the gene GFAP and central nervous system cancer.